SCHEMBL2863523

SCHEMBL2863523

C=CCOc1cc(OCC=C)c(C(=O)c2ccc(OCCOC3CCCCO3)c(OC)c2)c(CC(=O)OC)c1CC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
PTPN1 P18031 2/20 0.38
LMNA P02545 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
CREBBP Q92793 1/20 0.34
PDE4B Q07343 3/20 0.33
ALDH1A1 P00352 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862939 0.97 PTPN1 (0.38) KDM4EPTPN1LMNATDP1MEN1
SCHEMBL2866507 0.84 KDM4E (0.51) KDM4ELMNAMEN1KMT2APDE4B
SCHEMBL2861258 0.82 KDM4E (0.51) KDM4EMEN1KMT2ATLR8TLR7
SCHEMBL2859968 0.82 KDM4E (0.54) KDM4ELMNAMEN1KMT2APDE4B
SCHEMBL2856150 0.81 KDM4E (0.46) KDM4EMEN1KMT2APDE4BPDE4A
SCHEMBL2861716 0.81 KDM4E (0.45) KDM4ELMNAMEN1KMT2APDE4B
SCHEMBL2860139 0.80 LMNA (0.46) KDM4ELMNATLR8TLR7ALDH1A1
SCHEMBL5495545 0.80 KDM4E (0.41) KDM4ELMNATDP1MEN1KMT2A
SCHEMBL2859385 0.79 KDM4E (0.46) KDM4ETLR8TLR7PDE4BPDE4A
SCHEMBL2863526 0.79 KDM4E (0.40) KDM4EPTPN1LMNATDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP disclosed
US-7767693-B2 Hsp90 family protein inhibitors KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-08-03 US disclosed
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-10-01 US disclosed
US-7538224-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070032532-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-02-08 US disclosed
EP-1642880-A1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032532-A1 Hsp90 family protein inhibitors HSP90AB1, HSP90B1, HSP90AB2P KDM4E 2968/4885PTPN1 828/4885LMNA 4283/4885
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS HSP90AB1, HSP90B1, HSP90AB2P KDM4E 2968/4885PTPN1 828/4885LMNA 4283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.